Akebia Therapeutics, Inc.
DE ˙ DB ˙ US00972D1054
0,83 € ↓ -0,02 (-2,69%)
2026-06-03
DEL PRIS
SecurityDE:AX9 / Akebia Therapeutics, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership257,854 shares
Latest Disclosed Value $ 358,417
Man Group plc reports 23.61% increase in ownership of AX9 / Akebia Therapeutics, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 257,854 shares of Akebia Therapeutics, Inc. (DE:AX9) valued at $294,211 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 208,595 shares of Akebia Therapeutics, Inc.. This represents a change in shares of 23.61% during the quarter. The current value of the position is $214,225 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM 00972D105 257,854 49,259 23.61 358 6.87 0.0004
2026-02-17 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 208,595 84,169 67.65 336 -1.18 0.0006
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 124,426 82,715 198.31 340 124.50 0.0006
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 41,711 41,711 152 0.0003
2023-02-14 2022-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 0 -43,873 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 43,873 14 27.27 0.0001
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 11 0.0000
2021-08-16 2021-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -23,759 -100.00 0 -100.00
2021-05-17 2021-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 23,759 -119,047 -83.36 80 -80.00 0.0004
2021-02-16 2020-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 142,806 -4,732 -3.21 400 8.11 0.0018
2020-11-16 2020-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 147,538 -20,275 -12.08 370 -83.76 0.0015
2020-08-14 2020-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 167,813 -51,293 -23.41 2,278 37.15 0.0115
2020-05-15 2020-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 219,106 -121,069 -35.59 1,661 -22.74 0.0108
2020-02-18 2019-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 340,175 -25,172 -6.89 2,150 50.14 0.0071
2019-11-14 2019-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 365,347 -569,303 -60.91 1,432 -68.35 0.0053
2019-08-14 2019-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 934,650 346,242 58.84 4,524 -6.12 0.0164
2019-05-15 2019-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 588,408 190,604 47.91 4,819 119.05 0.0183
2019-02-14 2018-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 397,804 91,685 29.95 2,200 -18.61 0.0098
2018-11-14 2018-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 306,119 81,900 36.53 2,703 20.78 0.0099
2018-08-14 2018-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 224,219 22,800 11.32 2,238 16.56 0.0092
2018-05-15 2018-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 201,419 201,419 1,920 0.0088
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.